Literature DB >> 19318353

Interaction of adipocyte fatty acid-binding protein (AFABP) and JAK2: AFABP/aP2 as a regulator of JAK2 signaling.

Brian R Thompson1, Anna M Mazurkiewicz-Muñoz, Jill Suttles, Christin Carter-Su, David A Bernlohr.   

Abstract

Adipocyte fatty acid-binding protein (AFABP/aP2) facilitates the intracellular solubilization and trafficking of lipids within the aqueous environment of the cell. Studies in the AFABP/aP2 knock-out mouse suggest that the protein may have roles in cellular processes broader than lipid transport. We present herein the finding that AFABP/aP2 interacts with JAK2 in a fatty acid-dependent manner. This interaction was established using yeast two-hybrid analysis, co-immunoprecipitation from adipose tissue, and 3T3-L1 adipocytes as well as in 293 cells overexpressing JAK2 and AFABP/aP2. Mutational analysis of AFABP/aP2 (R126L/Y128F) revealed that fatty acid binding activity is necessary for the interaction and that Asp(18) of the helix-turn-helix motif forms a component of the interaction domain. Mutational analysis of JAK2 (Y1007F/Y1008F) revealed that AFABP/aP2 associates with the basal unphosphorylated form of the protein. Interleukin-6, but not interleukin-10, stimulated phosphorylation of STAT3, and induction of SOCS3 mRNA expression were potentiated in a time- and dose-dependent manner in macrophage cell lines derived from AFABP/aP2-EFABP/mal1 double knock-out mice relative to cells from wild type animals. These results suggest that ligand-bound AFABP/aP2 binds to and attenuates JAK2 signaling and establishes a new role for AFABP/aP2 as a fatty acid sensor affecting cellular metabolism via protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19318353      PMCID: PMC2679447          DOI: 10.1074/jbc.M900075200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  A family of cytokine-inducible inhibitors of signalling.

Authors:  R Starr; T A Willson; E M Viney; L J Murray; J R Rayner; B J Jenkins; T J Gonda; W S Alexander; D Metcalf; N A Nicola; D J Hilton
Journal:  Nature       Date:  1997-06-26       Impact factor: 49.962

Review 2.  STATs and gene regulation.

Authors:  J E Darnell
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

3.  Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130.

Authors:  M Narazaki; B A Witthuhn; K Yoshida; O Silvennoinen; K Yasukawa; J N Ihle; T Kishimoto; T Taga
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

4.  Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein.

Authors:  G S Hotamisligil; R S Johnson; R J Distel; R Ellis; V E Papaioannou; B M Spiegelman
Journal:  Science       Date:  1996-11-22       Impact factor: 47.728

5.  Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis.

Authors:  Bernhard Schieffer; Tina Selle; Andres Hilfiker; Denise Hilfiker-Kleiner; Karsten Grote; Uwe J F Tietge; Christian Trautwein; Maren Luchtefeld; Christian Schmittkamp; Sylvia Heeneman; Mat J A P Daemen; Helmut Drexler
Journal:  Circulation       Date:  2004-11-22       Impact factor: 29.690

6.  Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop.

Authors:  J Feng; B A Witthuhn; T Matsuda; F Kohlhuber; I M Kerr; J N Ihle
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

7.  The adipocyte lipid-binding protein at 1.6-A resolution. Crystal structures of the apoprotein and with bound saturated and unsaturated fatty acids.

Authors:  Z Xu; D A Bernlohr; L J Banaszak
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

8.  Modulation of ligand binding affinity of the adipocyte lipid-binding protein by selective mutation. Analysis in vitro and in situ.

Authors:  R S Sha; C D Kane; Z Xu; L J Banaszak; D A Bernlohr
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

9.  Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity.

Authors:  Lawrence S Argetsinger; Jean-Louis K Kouadio; Hanno Steen; Allan Stensballe; Ole N Jensen; Christin Carter-Su
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

10.  Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus.

Authors:  E Blasi; B J Mathieson; L Varesio; J L Cleveland; P A Borchert; U R Rapp
Journal:  Nature       Date:  1985 Dec 19-1986 Jan 1       Impact factor: 49.962

View more
  24 in total

1.  X-ray crystallographic analysis of adipocyte fatty acid binding protein (aP2) modified with 4-hydroxy-2-nonenal.

Authors:  Kristina Hellberg; Paul A Grimsrud; Andrew C Kruse; Leonard J Banaszak; Douglas H Ohlendorf; David A Bernlohr
Journal:  Protein Sci       Date:  2010-08       Impact factor: 6.725

Review 2.  Emerging roles of JAK-STAT signaling pathways in adipocytes.

Authors:  Allison J Richard; Jacqueline M Stephens
Journal:  Trends Endocrinol Metab       Date:  2011-05-10       Impact factor: 12.015

3.  Cellular growth and tube formation of HTR8/SVneo trophoblast: effects of exogenously added fatty acid-binding protein-4 and its inhibitor.

Authors:  Sanjay Basak; Arnab Sarkar; Santosh Mathapati; Asim K Duttaroy
Journal:  Mol Cell Biochem       Date:  2017-06-15       Impact factor: 3.396

Review 4.  A structure-function perspective of Jak2 mutations and implications for alternate drug design strategies: the road not taken.

Authors:  K Gnanasambandan; P P Sayeski
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

5.  Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1.

Authors:  Xiaoyan Hui; Huiying Li; Zhiguang Zhou; Karen S L Lam; Yang Xiao; Donghai Wu; Ke Ding; Yu Wang; Paul M Vanhoutte; Aimin Xu
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

6.  Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity.

Authors:  Hong Lan; Cliff C Cheng; Timothy J Kowalski; Ling Pang; Lixin Shan; Cheng-Chi Chuang; James Jackson; Alberto Rojas-Triana; Loretta Bober; Li Liu; Johannes Voigt; Peter Orth; Xianshu Yang; Gerald W Shipps; Joseph A Hedrick
Journal:  J Lipid Res       Date:  2011-02-04       Impact factor: 5.922

7.  A novel role for fatty acid transport protein 1 in the regulation of tricarboxylic acid cycle and mitochondrial function in 3T3-L1 adipocytes.

Authors:  Brian M Wiczer; David A Bernlohr
Journal:  J Lipid Res       Date:  2009-06-17       Impact factor: 5.922

8.  Identification and characterization of a small molecule inhibitor of Fatty Acid binding proteins.

Authors:  Ann V Hertzel; Kristina Hellberg; Joseph M Reynolds; Andrew C Kruse; Brittany E Juhlmann; Anne J Smith; Mark A Sanders; Douglas H Ohlendorf; Jill Suttles; David A Bernlohr
Journal:  J Med Chem       Date:  2009-10-08       Impact factor: 7.446

Review 9.  The role of JAK-STAT signaling in adipose tissue function.

Authors:  Allison J Richard; Jacqueline M Stephens
Journal:  Biochim Biophys Acta       Date:  2013-06-02

Review 10.  Metabolic functions of FABPs--mechanisms and therapeutic implications.

Authors:  Gökhan S Hotamisligil; David A Bernlohr
Journal:  Nat Rev Endocrinol       Date:  2015-08-11       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.